Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure With Tafenoquine or Primaquine After Quantitative G6PD Testing in Thailand

NCT05753150 is registered in ClinicalTrials.gov with Dr. Prayuth Sudathip as lead sponsor.

NCT NCT05753150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05753150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure With Tafenoquine or Primaquine After Quantitative G6PD Testing in Thailand
Lead sponsor
Dr. Prayuth Sudathip
Phase
Observational
Overall status
Completed
Start date
May 23, 2022
Completion date
October 1, 2023
Enrollment
187 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

g6pd deficiency, malaria, vivax